Search

everythinglearnresearchcommunity

for

Search:↓

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A woman developed lupus after taking hydroxyurea for two years.

Adding vitamin D to metformin lowers blood sugar more than metformin alone in type 2 diabetes.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

The injectable hydrogel effectively speeds up chronic wound healing.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

The gelatin-based hydrogel helps heal acute and diabetic wounds faster by improving healing conditions.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

An arthritis drug helped a person with severe hair loss regrow their hair.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.